| 1. Domain | 1.1 Scope of the Domain | Boundaries | The range of phenomena the science includes and excludes. | Examines hormone synthesis, secretion, circulation, receptor signaling, feedback loops, and organism-wide regulatory control. Includes endocrine glands, hormone–target interactions, metabolic regulation, stress responses, growth/reproductive control, and homeostatic adjustment. Excludes detailed molecular genetics and whole-organism behavior except where directly driven by hormonal regulation. |
| | Scale | The spatial, temporal, or organizational level at which the science operates (e.g., quantum, cellular, social, cosmic). | Operates from molecular (hormone–receptor binding) to tissue/organ-system scales (glandular secretion, multi-organ feedback). Timescales range from seconds (catecholamines) to hours–days (steroid signaling) to long-term developmental regulation. |
| 1.2 Ontological Commitments | Entities | The kinds of things assumed to exist within the domain (particles, organisms, agents, fields, etc.). | Hormones, receptors, endocrine glands, target tissues, signaling pathways, second messengers, feedback circuits, regulatory axes (HPA, HPG, HPT), carrier proteins, and metabolic effectors. |
| | Properties | The fundamental attributes these entities possess (mass, charge, genotype, preference, etc.). | Hormone concentration, receptor affinity, secretion rate, half-life, signal amplification, feedback sensitivity, metabolic effect strength, and rhythmicity (e.g., circadian release patterns). |
| | Categories | The basic ontological types used to classify domain elements (substances, processes, relations, structures). | Hormone types (peptide, steroid, amine), secretion modes (endocrine, paracrine, autocrine), regulatory axes, receptor classes, feedback types (positive/negative), and rhythmic regulation (ultradian, circadian). |
| 1.3 State-Variables | Variables | The measurable or definable properties that describe system conditions. | Plasma hormone levels, receptor density, downstream signaling-activity levels, secretion rates, metabolic readouts (glucose, lipids), ion balances, and feedback-loop set points. |
| | Parameterization | How variables encode and represent the system’s state. | State encoded through circulating hormone measurements, receptor-binding kinetics, second-messenger assays, metabolic markers, glandular output rates, and dynamic feedback analysis. |
| 1.4 Admissible Idealizations | Simplifications | Conceptual reductions used to make the domain tractable (point masses, rational agents, perfect gases). | Treating hormones as acting on single targets, modeling feedback as linear, assuming homogeneous tissue response, ignoring cross-talk between pathways, or approximating secretion rates as constant. |
| | Validity Conditions | The limits and contexts in which idealizations hold or break down. | Simplifications fail under complex multi-hormone interactions, receptor desensitization, nonlinear feedback dynamics, stress-induced state changes, or pathological endocrine disorders. |
| 1.5 Domain Assumptions | Structural Assumptions | Background ontological stances such as determinism, continuity, randomness, discreteness. | Assumes deterministic secretion mechanisms, stable receptor-binding rules, negative-feedback dominance, consistent signal-transduction behavior, and predictable endocrine system integration. |
| | Implicit Commitments | Unstated but necessary assumptions that shape the field’s conceptual structure. | Assumes hormones convey interpretable information, target tissues maintain consistent responsiveness, endocrine axes remain physiologically coordinated, and rhythmic release patterns reflect adaptive regulatory principles. |
| 1.6 Internal Coherence Requirements | Consistency | The demand that domain concepts do not contradict one another. | Hormone secretion, receptor binding, signaling cascades, and organ-level responses must align without contradictions across physiological conditions. |
| | Compatibility | The requirement that entities, variables, and assumptions fit together into a unified descriptive framework. | Entities (hormones, glands, receptors), variables (concentration, secretion rate, sensitivity), and assumptions (feedback, signal consistency) must fit into a unified regulatory framework. |
| 2. Evidence Layer | 2.1 Observable Phenomena | Observables | The aspects of the domain that can produce detectable signals accessible to measurement. | Plasma hormone levels, secretion pulses, metabolic readouts (glucose, lipids), receptor activation, downstream signaling activity, glandular output rhythms, stress-response markers, and electrolyte balance shifts. |
| | Detection Limits | The boundaries of what can be resolved or sensed by current instruments or methods. | Minimum detectable hormone concentration (often pg/mL), smallest measurable signaling change, detection limits of immunoassays, temporal resolution thresholds for pulsatile secretion, and sensitivity limits for metabolic sensors. |
| 2.2 Measurement Systems | Units | Standardized quantifications (meters, seconds, volts, decibels, dollars, etc.) necessary for consistent comparison. | pg/mL or ng/mL (hormones), molarity for second messengers, metabolic units (mg/dL glucose), receptor density units (fmol/mg tissue), secretion rates, and time (s–hours). |
| | Instruments | Devices and tools (microscopes, spectrometers, sensors, surveys, detectors) used to produce measurements. | Immunoassay systems (ELISA, RIA), mass spectrometers, glucose/lactate analyzers, calcium or cAMP reporters, endocrine imaging systems, microfluidic hormone samplers, and metabolic chambers. |
| 2.3 Operational Definitions | Definitions | Terms defined by specific measurement procedures, ensuring empirical clarity. | Definitions for “basal hormone level,” “pulsatile secretion,” “feedback response,” “receptor activation,” “stress hormone response,” and “metabolic regulatory shift,” each tied to measurable laboratory thresholds. |
| | Procedures | The explicit steps required to perform a measurement in a reproducible way. | Standard procedures including blood sampling protocols, ELISA/RIA workflows, dynamic endocrine-challenge tests, glucose-tolerance tests, clamp techniques, and imaging-based receptor-activation measurements. |
| 2.4 Data Acquisition | Protocols | Formal processes for gathering data under controlled or standardized conditions. | Time-series hormone sampling, circadian/circalunar timing protocols, serial metabolic measurements, endocrine challenge tests, and repeated monitoring of glandular or metabolic responses under controlled conditions. |
| | Sampling | Rules determining which subset of the domain is measured and how representative it is. | Choosing subjects, tissues, blood draws, time intervals, metabolic states (fed/fasted), circadian phases, and replicate numbers to ensure representative endocrine data. |
| 2.5 Data Character & Format | Data Types | The form raw evidence takes (time series, spectra, images, counts, qualitative records). | Hormone concentration curves, secretion-pulse profiles, dose–response tables, metabolic panels, second-messenger time series, receptor-binding graphs, and endocrine-challenge datasets. |
| | Resolution | The granularity or precision with which data is captured. | Temporal resolution (seconds to hours depending on hormone), concentration resolution (pg–ng/mL), metabolic resolution (single-digit mg/dL for glucose), and signaling-resolution limits in fluorescence or biochemical assays. |
| 2.6 Reliability & Calibration | Calibration | Adjustment procedures ensuring instruments produce accurate results. | Calibration of immunoassays with standards, metabolic-analyzer calibration, dynamic-range verification, reagent-validation steps, sensor calibration for electrolytes/metabolites, and drift-correction protocols. |
| | Error Characterization | Identification and quantification of noise, uncertainty, bias, and measurement error. | Sources of error include assay cross-reactivity, sample degradation, circadian variability, stress-induced artifacts, instrument noise, batch effects, and biological heterogeneity in hormone responses. |
| 3. Structural Layer | 3.1 Patterns & Regularities | Laws / Relations | Stable, repeatable patterns governing how observables behave across conditions. | Core relationships such as dose–response curves, feedback-control equations, receptor-binding kinetics, hormone–receptor affinity rules, pulsatile vs tonic secretion patterns, and homeostatic set-point regulation. |
| | Invariants | Quantities or properties that remain constant under transformations (symmetries, conservation laws). | Stable regulatory constants: receptor–ligand affinity ranges, half-lives of major hormones, baseline circadian rhythms, conserved negative-feedback architectures, and characteristic endocrine-axis gain values. |
| 3.2 Causal Architecture | Mechanisms | Underlying processes or structures that produce the observed regularities. | Hormone synthesis and secretion, receptor activation, second-messenger cascades, transcriptional regulation, metabolic pathway modulation, and integrated multi-organ feedback loops (HPA, HPG, HPT axes). |
| | Pathways | Organized sequences of interactions forming a causal chain or network. | Ordered regulatory sequences such as hypothalamic release → pituitary secretion → target-gland activation → endocrine feedback; or glucose rise → insulin secretion → cellular uptake → metabolic normalization. |
| 3.3 Theoretical Vocabulary | Concepts | Core terms that encode the domain’s structure (force, gene, equilibrium, field). | Set point, feedback loop, receptor affinity, endocrine axis, hormonal rhythm, amplification, sensitivity, desensitization, secretion pulse, trophic hormone, and regulatory gain. |
| | Classifications | Taxonomies, categories, or typologies that organize entities and relations. | Hormone categories (peptide, steroid, amine), secretion modes (endocrine/paracrine/autocrine), receptor classes (GPCR, nuclear receptor, RTK), feedback types, and regulatory-axis structures. |
| 3.4 Formal Representations | Equations | Mathematical constructs expressing laws, relations, or mechanisms. | Receptor-binding curves, Hill equations, feedback-control equations, secretion-rate formulas, endocrine mass-balance equations, and rate-law expressions for enzymatic metabolic control. |
| | Models | Structured representations—mathematical, computational, or conceptual—used to predict and explain phenomena. | Dynamic feedback-loop models, multi-hormone interaction models, circadian rhythm models, metabolic regulation models, receptor-occupation models, and system-wide endocrine-network simulations. |
| 3.5 Idealized Structures | Simplified Models | Purposeful abstractions that capture essential dynamics while omitting irrelevant detail. | Linear feedback models, single-hormone control frameworks, homogeneous target-tissue assumptions, simplified receptor-binding kinetics, or ignoring hormone degradation variability. |
| | Limit Conditions | Regimes where specific models or approximations hold (classical vs. quantum, linear vs. nonlinear). | Valid under stable physiological states, normal metabolic load, consistent receptor expression, and moderate hormonal variation; fail under stress, disease, extreme metabolic demand, or strong pathway cross-talk. |
| 3.6 Integrative Frameworks | Unifying Theories | Higher-order structures that connect disparate laws or mechanisms under a coherent whole. | Homeostasis theory, endocrine-axis integration, metabolic-regulation frameworks, circadian endocrine coordination, and systemic control-theory models of gland–organ–metabolic interactions. |
| | Interdisciplinary Links | Points where the theory connects to adjacent sciences or larger explanatory systems. | Strong connections to physiology, biochemistry, neuroendocrinology, metabolism, immunology, behavioral biology, and systems biology through shared principles of signaling and feedback regulation. |
| 4. Method Layer | 4.1 Inquiry Design | Experimental Design | Structured plans for manipulating variables to test causal claims. | Manipulating hormone levels (injection, infusion, suppression), altering receptor activity (agonists/antagonists), applying endocrine-challenge tests, modifying metabolic load, or inducing controlled stressors to test causal regulatory responses. |
| | Observational Design | Systematic approaches for gathering non-manipulated data (surveys, field studies, natural experiments). | Recording natural hormonal rhythms, basal secretion patterns, metabolic states, and feedback responses through serial sampling and continuous monitoring without imposed interventions. |
| 4.2 Testing & Validation | Hypothesis Testing | Procedures for evaluating whether evidence supports or contradicts specific claims. | Testing predictions about hormonal control, feedback strength, receptor sensitivity, metabolic regulation, or endocrine-axis interactions using structured challenges (glucose-tolerance tests, ACTH tests, suppression tests). |
| | Replication | The requirement that results be independently reproducible under similar conditions. | Repeating hormone assays, metabolic tests, receptor-binding experiments, and dynamic-challenge protocols across subjects, conditions, and time to ensure reliability. |
| 4.3 Inference & Evaluation | Statistical Inference | Rules for drawing conclusions from noisy or incomplete data. | Using regression, nonlinear modeling, mixed-effects frameworks, dose–response analysis, time-series modeling, and Bayesian inference to interpret hormone, receptor, and metabolic data. |
| | Model Comparison | Criteria (fit, simplicity, predictive accuracy, robustness) used to evaluate competing models. | Comparing alternative feedback-loop models, endocrine-axis models, metabolic-regulation frameworks, and receptor-kinetics models based on fit, stability, predictive power, and biological plausibility. |
| 4.4 Error Management | Error Analysis | Identification and quantification of random and systematic errors. | Identifying assay noise, sample-handling errors, cross-reactivity artifacts, timing inconsistencies, metabolic variability, biological heterogeneity, and signal-drift in dynamic endocrine measurements. |
| | Bias Control | Methods for minimizing subjective, instrumental, or procedural biases. | Standardizing sampling times (circadian control), blinding assay interpretation, calibrating immunoassays, using reference standards, minimizing subject stress, and matching metabolic conditions across trials. |
| 4.5 Adjudication & Revision | Peer Scrutiny | Collective evaluation of claims through critique, review, and debate. | Independent evaluation of endocrine-model claims, metabolic interpretations, feedback analyses, and hormone-effect attributions via peer review and cross-lab comparison. |
| | Theory Revision | Procedures for modifying, replacing, or discarding models based on new evidence. | Updating secretion models, feedback frameworks, hormone–receptor interaction rules, or metabolic-regulation theories when new evidence challenges existing assumptions. |
| 4.6 Integrity Conditions | Transparency | Requirements to disclose methods, data, assumptions, and limitations. | Full reporting of sample timing, assay methods, stimulus protocols, metabolic conditions, calibration steps, and all modeling assumptions. |
| | Ethical Standards | Norms ensuring responsible conduct in experimentation, data handling, and publication. | Ethical sampling procedures, careful handling of animal or human subjects, minimizing endocrine disruption, honest reporting, and adherence to biomedical experimentation standards. |